Our scientific team is comprised of biologists, virologists and medicinal chemists with extensive drug discovery and development experience. Our efforts are further supported by a host of highly experienced collaborators and through funding from the National Institute for Allergy and Infectious Disease.
Dr. McCormack, who previously held scientific and management positions at Narogen, Icagen and Vertex Pharmaceuticals, manages the corporate activities and R&D operations.
Dr. Henkel oversees R&D operations directing biology and drug development efforts. Dr. Henkel previously led drug development programs as Director of Biology at Vertex Pharmaceuticals.
Ms. Howard manages accounting and financial operations.
Mr. Murphy is responsible for database and IT systems management.